Assessing the Annual Economic Burden of Preventing and Treating Anogenital Human Papillomavirus-Related Disease in the US
Data up to Jan 2025
Total Citations Per Year
Abstract
References (95)
Methods for the Economic Evaluation of Health Care Programmes
2005 • 11,095 citations
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
1999 • 8,737 citations
Cost-Effectiveness in Health and Medicine
1996 • 6,853 citations
Cancer Statistics, 2005
2005 • 5,487 citations
Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers
2000 • 3,004 citations
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
2004 • 1,624 citations
A Controlled Trial of a Human Papillomavirus Type 16 Vaccine
2002 • 1,570 citations
2001 Consensus Guidelines for the Management of Women With Cervical Cytological Abnormalities
2002 • 1,232 citations
The Pap Test and Bethesda 2014
2015 • 1,122 citations
Epidemiology of Genital Human Papillomavirus Infection
1997 • 1,122 citations
Accuracy of the Papanicolaou Test in Screening for and Follow-up of Cervical Cytologic Abnormalities
2000 • 1,089 citations
Estimating Health Care Costs Related to Cancer Treatment From SEER-Medicare Data
2002 • 907 citations
The Hidden Epidemic
1997 • 749 citations
EPIDEMIOLOGY OF GENITAL HUMAN PAPILLOMAVIRUS INFECTION
1988 • 700 citations
Estimates of the Incidence and Prevalence of Sexually Transmitted Diseases in the United States
1999 • 591 citations
Identifying Women With Cervical Neoplasia
1999 • 586 citations
Interim Guidelines for Management of Abnormal Cervical Cytology
1994 • 542 citations
The Relation between Funding by the National Institutes of Health and the Burden of Disease
1999 • 493 citations
Evaluation of Human Papillomavirus Testing in Primary Screening for Cervical Abnormalities
2002 • 453 citations
The Estimated Direct Medical Cost of Sexually Transmitted Diseases Among American Youth, 2000
2004 • 431 citations
Task Force on Recurrent Respiratory Papillomas: A Preliminary Report
1995 • 422 citations
Using the World Health Organization Health and Work Performance Questionnaire (HPQ) to Evaluate the Indirect Workplace Costs of Illness
2004 • 415 citations
Quality of Care
1994 • 412 citations
Concordance of Self-reported Data and Medical Record Audit for Six Cancer Screening Procedures
1993 • 412 citations
Cancer and infection: estimates of the attributable fraction in 1990.
1997 • 394 citations
Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop
1994 • 357 citations
External Genital Warts: Diagnosis, Treatment, and Prevention
2002 • 355 citations
The Medical Expenditure Panel Survey: a national health information resource.
1996 • 335 citations
Cost Effectiveness of a Potential Vaccine forHuman papillomavirus
2003 • 321 citations
2001 Consensus Guidelines for the management of women with cervical intraepithelial neoplasia
2003 • 302 citations
Human Papillomavirus and head and neck cancer: Epidemiology and molecular biology
1998 • 302 citations
Recurrent Respiratory Papillomatosis: A Longitudinal Study Comparing Severity Associated With Human Papilloma Viral Types 6 and 11 and Other Risk Factors in a Large Pediatric Population
2004 • 288 citations
Diagnoses and outcomes in cervical cancer screening: A population-based study
2004 • 254 citations
Cancer prevention and control.
1990 • 226 citations
The Health and Economic Burden of Genital Warts in a Set of Private Health Plans in the United States
2003 • 223 citations
Accuracy of Self-Reported Health Services Use and Patterns of Care Among Urban Older Adults
1999 • 211 citations
2001 Consensus Guidelines for the Management of Women with Cervical Cytological Abnormalities
2002 • 200 citations
Cervical biopsy-cytology correlation. A College of American Pathologists Q-Probes study of 22 439 correlations in 348 laboratories.
1996 • 191 citations
Accuracy of Self-Report of Mammography and Pap Smear in a Low-Income Urban Population
1998 • 191 citations
Annual cost of bipolar disorder to UK society
2002 • 190 citations
Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites.
2001 • 181 citations
An international survey of patients with genital warts: perceptions regarding treatment and impact on lifestyle
1998 • 174 citations
The frequency of Pap smear screening in the United States
2004 • 173 citations
Condyloma Acuminatum in Rochester, Minn, 1950-1978
1984 • 165 citations
Atypical squamous cells of undetermined significance: Interlaboratory comparison and quality assurance monitors
1994 • 160 citations
The psychosocial impact of human papillomavirus infection: implications for health care providers
1996 • 148 citations
Incidence and Prevalence of Recurrent Respiratory Papillomatosis among Children in Atlanta and Seattle
2000 • 146 citations
Cost Effectiveness of Cervical Cancer Screening for the Elderly
1992 • 143 citations
The health care costs of cervical human papillomavirus–related disease
2004 • 138 citations
Adult Respiratory Papillomatosis: Human Papillomavirus Type and Viral Coinfections as Predictors of Prognosis
1995 • 133 citations
Quality management in gynecologic cytology using interlaboratory comparison.
2000 • 118 citations
Correlates of underutilization of gynecological cancer screening among lesbian and heterosexual women
2003 • 114 citations
Where Do People Go for Treatment of Sexually Transmitted Diseases?
1999 • 114 citations
Quality Management in Gynecologic Cytology Using Interlaboratory Comparison
2000 • 113 citations
Genital Warts and Their Treatment
1999 • 112 citations
The Costs, Clinical Benefits, and Cost-Effectiveness of Screening for Cervical Cancer in HIV-Infected Women
1999 • 108 citations
Pediatric Respiratory Papillomatosis: Prognostic Role of Viral Typing and Cofactors
1997 • 105 citations
Costs of Illness in Cost-Effectiveness Analysis
1994 • 104 citations
The Multinational Impact of Migraine Symptoms on Healthcare Utilisation and Work Loss
2001 • 100 citations
Is HIV infection a cofactor for cervical squamous cell neoplasia?
1999 • 98 citations
Genital Human Papillomavirus Infection
1987 • 95 citations
The Cost of Juvenile-Onset Recurrent Respiratory Papillomatosis
2000 • 89 citations
The Economic Burden of Cancer
1998 • 81 citations
The Economic Cost of Squamous Cell Cancer of the Head and Neck
2004 • 80 citations
PAPNET-Assisted Rescreening of Cervical Smears
1998 • 77 citations
Accuracy of patients' recall of Pap and cholesterol screening
2000 • 77 citations
The Measurement of Indirect Costs in the Health Economics Evaluation Literature:A Review
1998 • 76 citations
Patients Attending STD Clinics in an Evolving Health Care Environment
1997 • 75 citations
Cigarette Smoking, Oncogenic Human Papillomavirus, Ki-67 Antigen, and Cervical Intraepithelial Neoplasia
2004 • 75 citations
Are adolescents accurate in self-report of frequencies of sexually transmitted diseases and pregnancies?
1997 • 73 citations
Predictors of compliance with recommended cervical cancer screening schedule: a population-based study.
1999 • 69 citations
Distress after an abnormal Pap smear result: scale development and psychometric validation
2004 • 66 citations
Condylomata Acuminata (Genital Warts)
2001 • 65 citations
Risk factors for injury among construction workers at Denver International Airport
1998 • 64 citations
Public or Private Providers? U.S. Women's Use of Reproductive Health Services
2001 • 64 citations
Current cervical neoplasia screening practices of obstetrician/gynecologists in the US
2005 • 60 citations
Projection of the Future Dimensions and Costs of the Genital Herpes Simplex Type 2 Epidemic in the United States
2002 • 57 citations
TIME COSTS ASSOCIATED WITH CERVICAL CANCER SCREENING
2001 • 56 citations
Rescreening in gynecologic cytology. Rescreening of 3762 previous cases for current high-grade squamous intraepithelial lesions and carcinoma--a College of American Pathologists Q-Probes study of 312 institutions.
1995 • 53 citations
Pap Screening in a U.S. Health Plan
2004 • 53 citations
Impact of the bethesda system
1995 • 52 citations
Preventing Emerging Infectious Diseases: A Strategy for the 21st Century: Overview of the Updated CDC Plan
1998 • 49 citations
Progress in prophylactic and therapeutic vaccines for human papillomavirus infection
2003 • 49 citations
Cost-Effectiveness Analysis of Diagnosis and Management of Cervical Squamous Intraepithelial Lesions
1998 • 49 citations
Human papillomavirus-associated carcinomas in Hawaii and the mainland U.S.
2000 • 45 citations
Determining Costs of Health Care Services for Cost-Effectiveness Analyses
1999 • 43 citations
The economic burden of gynecologic cancers in California, 1998
2003 • 39 citations
Burden of Migraine in Brazil: Estimate of Cost of Migraine to the Public Health System and an Analytical Study of the Cost‐Effectiveness of a Stratified Model of Care
2003 • 38 citations
The effect of additional shots on the vaccine administration process: results of a time-motion study in 2 settings.
2000 • 37 citations
Comparing Claims Data and Self-Reported Data with the Medical Record for Pap Smear Rates
1997 • 37 citations
Long-Term Outcome and Relative Risk in Women With Atypical Squamous Cells of Undetermined Significance
1999 • 35 citations
The Value of Repeat Pap Smear at the Time of Initial Colposcopy
1997 • 28 citations
THE COST OF TREATING GENITAL WARTS
1996 • 27 citations
Validity of Self‐Reporting of Episodes of External Genital Warts
2002 • 23 citations
Adolescent HMO enrollees’ utilization of out-of-plan services
2001 • 17 citations
Cited By (0)
No citing papers found in database